Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

11:09 AM ET 8-K/A
M&A Deal Clear Channel Outdoor Holdings, Inc. CCO

Clear Channel Outdoor Holdings Signs $1.3B M&A Deal with MIC Capital Management UK LLP

Clear Channel Outdoor Holdings, Inc. completed its merger on October 14, 2026, resulting in a change of control where the company became a wholly owned subsidiary of an affiliate of Mubadala. The total cash consideration paid to equityholders was approximately $1.3 billion, funded by $2.9 billion in equity investments from Mubadala-affiliated funds and incremental term loans.

Value
$1.3B
Counterparty
MIC Capital Management UK LLP (Mubadala)
10:00 AM ET 8-K
M&A Deal Copart Inc CPRT

Copart Signs $1.79B M&A Deal with ACV Auctions Inc.

Copart, Inc. completed its acquisition of ACV Auctions Inc. for $10.50 per share in cash following a successful tender offer in which approximately 68.43% of shares were tendered. The transaction combines Copart's global auction network with ACV's dealer and wholesale remarketing platform, with ACV now operating as a wholly owned subsidiary.

Value
$1.79B
Counterparty
ACV Auctions Inc.

“With ACV now part of the Copart family, we have established an industry-leading, fully complete remarketing platform spanning dealer trade-ins, wholesale remarketing, salvage disposition, and international scale.”

Jay Adair, Chief Executive Officer of Copart

“Joining with Copart amplifies this mission, supercharging our growth, pace of innovation and global reach.”

George Chamoun, CEO of ACV
9:48 AM ET 8-K
Bankruptcy & Restructuring Cumulus Media Inc CMLSQ

Cumulus Media Bankruptcy & Restructuring

Cumulus Media Inc. has successfully emerged from Chapter 11 bankruptcy protection, completing a financial restructuring that eliminated approximately $550 million of debt. As part of the reorganization, the company canceled all existing equity and issued new common stock and $50 million in convertible notes to former lenders, while also entering into a new $100 million ABL credit facility.

“I am grateful to our lenders and noteholders for their collaboration throughout this process, and to our employees, vendors, affiliates, customers, and partners for their continued trust and support. Emerging with a significantly stronger balance sheet, we are more committed than ever to providing engaging content across our national footprint, serving as a lifeline and voice for the local communities we serve, driving meaningful growth for our advertising partners, and delivering value for our new shareholders.”

Mary G. Berner, President and Chief Executive Officer of Cumulus Media
9:21 AM ET 8-K
M&A Deal Sanara MedTech Inc. SMTI

Sanara MedTech M&A Deal with MiMedx Group, Inc.

Sanara MedTech and MiMedx Group received a 'Second Request' for information from the FTC regarding their pending merger. This request extends the HSR Act waiting period until 30 days after both parties substantially comply with the request, unless terminated earlier by the FTC.

Counterparty
MiMedx Group, Inc.
9:01 AM ET 8-K
M&A Deal Mimedx Group, Inc. MDXG

Mimedx Group M&A Deal with Sanara MedTech Inc.

MiMedx Group and Sanara MedTech each received a 'Second Request' for information from the FTC regarding their pending merger. This action extends the HSR Act waiting period until 30 days after both parties substantially comply with the request, unless terminated earlier by the regulator.

Counterparty
Sanara MedTech Inc.
9:00 AM ET 8-K
M&A Deal New Mountain Net Lease Trust NEWLEASE

New Mountain Net Lease Trust Signs $2.4B M&A Deal with New Mountain Net Lease Partners II, L.P.

New Mountain Net Lease Trust has entered into a definitive agreement to acquire a $2.4 billion real estate portfolio from New Mountain Net Lease Partners II, L.P. The portfolio consists of 180 industrial net-leased properties totaling over 18 million square feet with a 15-year weighted average remaining lease term. The transaction is expected to close around January 1, 2027, and will be financed through cash, the assumption of $1.3 billion in debt, and the issuance of new shares.

Value
$2.4B
Counterparty
New Mountain Net Lease Partners II, L.P.
Term
15 years
8:31 AM ET 8-K
M&A Deal MiniMed Group, Inc. MMED

MiniMed Group M&A Deal with Medtronic plc

MiniMed Group, Inc. completed its separation from Medtronic plc through an exchange offer where Medtronic accepted 55,032,401 of its own shares in exchange for 252,813,348 shares of MiniMed common stock. As a result, Medtronic no longer owns any shares of MiniMed, making it a fully independent company. The filing also reports related board resignations and the appointment of Amy Bricker as a new independent director.

Counterparty
Medtronic plc
8:30 AM ET 8-K
M&A Deal Blink Charging Co. BLNK

Blink Charging Signs $12.5M M&A Deal with CID HoldCo, Inc.

Blink Charging Co. announced an update regarding its previously divested Envoy Technologies business, which has now been sold by BladeRanger to CID HoldCo, Inc. As part of the transaction, a $12.5 million convertible promissory note held by Blink was amended to convert into 2,166,667 shares of CID common stock upon the satisfaction of certain Nasdaq and SEC regulatory conditions.

Value
$12.5M
Counterparty
CID HoldCo, Inc.
Term
through July 2029
8:24 AM ET 8-K/A
M&A Deal Brady Corp BRC

Brady M&A Deal with Honeywell International Inc.

Brady Corporation completed its acquisition of Honeywell International Inc.’s Productivity Solutions and Services business on August 3, 2026. This filing serves as an amendment to provide the required audited financial statements and pro forma financial information for the acquired business. The transaction was originally executed under an Equity Purchase Agreement dated April 20, 2026.

Counterparty
Honeywell International Inc.
8:00 AM ET 8-K
Capital Raise Strive, Inc. ASST

Strive Capital Raise of $630M

Strive, Inc. priced an upsized initial public offering of 7,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock at $90.00 per share, generating gross proceeds of approximately $630 million. The company intends to use the proceeds for general corporate purposes, including the acquisition of bitcoin and bitcoin-related products, working capital, and potential share repurchases.

Value
$630M
Counterparty
Barclays Capital Inc. and Cantor Fitzgerald & Co.
7:42 AM ET 8-K
Contract Win Cycurion, Inc. CYCU

Cycurion Wins $54.6M Contract from global consulting firm

Cycurion announced a $54.6 million, 10-year contract to modernize and securely operate a major state Health and Human Services system. The contract, which is the largest in the company's history, is expected to generate over $5 million in annual recurring revenue with work commencing in November 2026.

Value
$54.6M
Counterparty
global consulting firm
Term
10 years
7:01 AM ET 8-K
Clinical Trial Data Fractyl Health, Inc. GUTS

Fractyl Health Clinical Trial Data

Fractyl Health announced positive topline six-month results from its REMAIN-1 Pivotal Cohort study evaluating the Revita DMR System for weight maintenance after GLP-1 therapy discontinuation. The study met its six-month co-primary endpoint with high statistical significance (p=0.0023), showing that Revita participants retained 80% of their weight loss compared to 67% for the sham group. The company plans to submit a De Novo marketing application to the FDA in late Q4 2026 based on these results.

7:01 AM ET 8-K
Licensing Deal RYTHM, Inc. RYM

RYTHM Licensing Deal with GTI Core, LLC

RYTHM, Inc.'s subsidiary VCP IP Holdings amended its licensing agreement with Green Thumb Industries' subsidiary GTI Core to add the Señorita brand to the licensed intellectual property. In exchange for the additional rights, the base licensing fees paid to RYTHM will increase by $250,000 per year.

Counterparty
GTI Core, LLC
6:04 AM ET 8-K
M&A Deal International Seaways, Inc. INSW

International Seaways Signs $370M M&A Deal with Bruton Limited

International Seaways (INSW) entered into a definitive agreement to acquire Bruton Limited in a transaction valuing the target at approximately $370 million. The deal involves a two-step process: an immediate exchange for 50.5% of Bruton's shares followed by a merger for the remaining shares, primarily using INSW common stock at an exchange ratio of 0.05190 per Bruton share.

Value
$370M
Counterparty
Bruton Limited

“We're excited about the opportunity to expand and modernize our fleet through this accretive transaction with Bruton. The transaction underscores our disciplined approach to growth. Following completion of the transaction, Seaways will remain well-positioned to continue executing on our growth strategy, generating attractive returns and creating long-term value for our shareholders.”

Lois K. Zabrocky, International Seaways President and CEO
6:04 AM ET 8-K/A
M&A Deal Ensysce Biosciences, Inc. ENSC

Ensysce Biosciences M&A Deal with Cy Biopharma, Inc.

Ensysce Biosciences completed the acquisition of Cy Biopharma, Inc. on August 5, 2026, through a two-step merger process. As consideration, Ensysce issued 282,122 shares of Series C Preferred Stock to Cy Biopharma equityholders, with each share convertible into 1,000 shares of common stock. This filing (Amendment No. 2) provides required historical and pro forma financial statements related to the transaction.

Counterparty
Cy Biopharma, Inc.
6:02 AM ET 8-K
M&A Deal Skydance Corp SKYD

Skydance M&A Deal with Warner Bros. Discovery, Inc.

Skydance Corporation completed its merger with Warner Bros. Discovery, Inc. on October 6, 2026, and subsequently distributed 470,746,773 warrants to Class B stockholders as a dividend. The filing also provides a status update regarding a temporary trading blackout period for the company's 401(k) plan and executive officers to facilitate the conversion of plan assets following the merger.

Counterparty
Warner Bros. Discovery, Inc.
6:00 AM ET 8-K
Bankruptcy & Restructuring Sangamo Therapeutics, Inc SGMOQ

Sangamo Therapeutics Bankruptcy & Restructuring

Sangamo Therapeutics, Inc. filed a monthly operating report (MOR) for August 2026 as part of its ongoing Chapter 11 bankruptcy proceedings in the District of Delaware. The report discloses a month-end cash balance of $23.2 million and total liabilities of $107.3 million. Additionally, the company's common stock is being delisted from Nasdaq effective October 17, 2026, following its suspension in May 2026.

5:25 PM ET 8-K
M&A Deal FG Communities Holdings Inc. FGC

FG Communities Holdings M&A Deal with unaffiliated third party

FG Communities Holdings Inc. completed the acquisition of two manufactured housing communities in North Carolina, located in Garner and Mars Hill. The acquisitions added a combined 78 homesites across 78 acres to the company's portfolio and were funded using cash on hand.

Counterparty
unaffiliated third party
5:23 PM ET 8-K
Clinical Trial Data Opus Genetics, Inc. IRD

Opus Genetics Clinical Trial Data

Opus Genetics presented positive clinical data from its OPGx-BEST1 and OPGx-LCA5 gene therapy programs at the Retina in Rio 2026 conference. OPGx-BEST1 showed improved retinal sensitivity in 75% of Cohort 1 participants, while OPGx-LCA5 demonstrated sustained visual improvements through 24 months in adults and 6 months in pediatric patients.

5:21 PM ET 8-K
M&A Deal Varonis Systems Inc VRNS

Varonis Systems Signs $6.3B M&A Deal with Proofpoint, Inc.

Varonis Systems has entered into a definitive agreement to be acquired by Proofpoint, Inc., a portfolio company of Thoma Bravo, in an all-cash transaction valued at approximately $6.3 billion. Varonis shareholders will receive $49.75 per share in cash, representing a 52% premium to the company's unaffected stock price. The deal is expected to close in the first half of 2027 and will create a unified cybersecurity platform focused on data and AI security.

Value
$6.3B
Counterparty
Proofpoint, Inc.
Term
through first half of 2027
5:19 PM ET 8-K
Licensing Deal Biohaven Ltd. BHVN

Biohaven Licensing Deal with Ono Pharmaceutical Co., Ltd. Worth $100M

Biohaven granted Ono Pharmaceutical an exclusive license to develop and commercialize its MoDE pan IgG degrader portfolio, including lead candidate BHV-1300, in Japan, South Korea, Taiwan, and ASEAN countries. Biohaven receives an $80 million upfront payment and is eligible for a $20 million milestone payment plus royalties of approximately 20% on net sales in the territory.

Value
$100M
Counterparty
Ono Pharmaceutical Co., Ltd.
5:16 PM ET 8-K
M&A Deal SPACSphere Acquisition Corp. SSAC

SPACSphere Acquisition M&A Deal with Mobilewalla Holdco, Inc.

SPACSphere Acquisition Corp. entered into an amendment to its existing business combination agreement with Mobilewalla Holdco, Inc. to increase the size of the post-merger board of directors from five to seven members. The amendment also specifies the initial director designees for the combined company, which will be renamed Covariate, Inc. upon the closing of the transaction.

Counterparty
Mobilewalla Holdco, Inc.
5:01 PM ET 8-K
Capital Raise Pine Tree Acquisition Corp. PAXG

Pine Tree Acquisition Capital Raise of $6M

Pine Tree Acquisition Corp. consummated the sale of 600,000 additional units at $10.00 per unit following the partial exercise of the underwriter's over-allotment option. The transaction generated $6 million in gross proceeds, bringing the total amount held in the company's trust account to $106 million.

Value
$6M
Counterparty
Maxim Group LLC
4:37 PM ET 8-K
Capital Raise Blackstone Real Estate Income Trust, Inc. BSTT

Blackstone Real Estate Income Trust Capital Raise of $10.3M

Blackstone Real Estate Income Trust, Inc. sold unregistered shares of its Class C common stock to investment vehicles for aggregate consideration of approximately $10.3 million. The sales occurred in two tranches on September 1 and October 1, 2026, and were conducted as private placements exempt from registration under Section 4(a)(2) and Regulation S.

Value
$10.3M
Counterparty
certain investment vehicles
4:35 PM ET 8-K
Capital Raise Crypto Co CRCW

Crypto Capital Raise

The Crypto Company entered into subscription agreements to raise $75,000 through a private placement of 97,165,533 shares of common stock. The consideration consisted of $65,000 in cash and 3.4683 ETH, with one of the investors being an entity managed by the company's Chief Strategy Officer.

Counterparty
James Smittkamp and Three Mile Creek Future LLC
4:31 PM ET 8-K
Bankruptcy & Restructuring Greenlane Holdings, Inc. GNLN

Greenlane Holdings Bankruptcy & Restructuring

Greenlane Holdings' subsidiaries filed petitions in the Florida Circuit Court to commence assignment proceedings for the benefit of creditors. The court has assumed jurisdiction over the assets of Warehouse Goods LLC, Greenlane Holdings LLC, KIM International LLC, and Kush Supply Co. LLC, which will be liquidated by an assignee to pay creditors.

Counterparty
Philip J. von Kahle
4:29 PM ET 8-K
Capital Raise First Tracks Biotherapeutics, Inc. TRAX

First Tracks Biotherapeutics Capital Raise of $200M

First Tracks Biotherapeutics entered into a securities purchase agreement for a $200 million private placement (PIPE) of 6,106,870 shares of common stock at $32.75 per share. The offering includes participation from several institutional investors and is intended to fund the clinical development of ANB033 and other general corporate purposes.

Value
$200M
Counterparty
Affinity Asset Advisors, LLC, First Light Asset Management, Sirenia Capital Management LP, TCGX, Trails Edge Capital Partners, Vestal Point Capital
4:25 PM ET 8-K
M&A Deal Daily Journal Corp DJCO

Daily Journal M&A Deal with Revir Technologies, Inc.

Daily Journal Corporation completed the acquisition of Austin-based software company Revir Technologies, Inc. on October 13, 2026. Revir, which provides the Scout AI-powered digital evidence management platform for law enforcement and public safety agencies, will operate independently within Daily Journal's Courts, Justice, and Government Technology division.

Counterparty
Revir Technologies, Inc.
4:24 PM ET 8-K
Capital Raise Frazier Life Sciences Acquisition Corp. II FLSC

Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M

Frazier Life Sciences Acquisition Corp. II consummated its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds. Simultaneously, the company's sponsor purchased 300,000 private placement shares for an additional $3 million, and a forward purchase agreement was established for at least $25 million to be funded at the time of a future business combination.

Value
$78M
Counterparty
Jefferies LLC
4:18 PM ET 8-K
M&A Deal Indivior Pharmaceuticals, Inc. SUPN

Indivior Pharmaceuticals M&A Deal Update

Stockholders of Indivior Pharmaceuticals, Inc. approved the issuance of common stock in connection with a previously announced merger agreement. The vote satisfies Nasdaq Rule 5635 requirements for the share issuance, marking a key step toward completing the acquisition.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.